Fig. 4
From: Cardiovascular outcomes between COVID-19 and non-COVID-19 pneumonia: a nationwide cohort study
Subgroup analyses comparing the risk of cardiovascular outcomes in participants hospitalized for COVID-19 or non-COVID-19 pneumonia. The hazard ratios and 95% CIs have been estimated in the inverse probability of treatment-weighted COVID-19 (n = 125,810) and non-COVID-19 pneumonia (n = 28,492) groups. CI confidence interval, COVID-19 coronavirus disease 2019, MACE major adverse cardiovascular event. * A composite of myocardial infarction and stroke